Characteristics of Cancer Stem Cells (CSCs)

Size: px
Start display at page:

Download "Characteristics of Cancer Stem Cells (CSCs)"

Transcription

1 GENReports: Market & Tech Analysis Characteristics of Cancer Stem Cells (CSCs) > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director Select Biosciences, Inc.

2 Topic,IntroducEon,and,Scope! The,focus,of,this,GEN,Market,&,Tech,Analysis,Report,is,to,frame,the, challenging,space,of,cancer,stem,cells,(cscs), CSC,research,and,clinical,translaEon,has,been,hampered,by,the,lack,of, bona% fide% characterisecs, of, this, cellular, class, and, agreement, within, the,research,community,as,to,their,role,in,metastaec,development, Indeed,!many!have!ques?oned!the!existence!of!CSCs!in#vivo# Do! CSCs! originate! from! the! primary! tumor! and! then! traffic! within! the! circula?on!to!distal!sites!to!give!rise!to!metastases?! What! is! the! rela?onship! between! circula?ng! tumor! cells! (CTCs)! which! are! known!to!be!increased!in!number!in!the!circula?on!of!cancer!pa?ents!visoào vis!cscs?!!!!is!one!cellular!class!the!progenitor?! The,challenge,in,the,study,of,CSCs,is,compounded,by,the,fact,that,the, surface,phenotype,of,bona%fide%cscs,is,controversial, In,this,GEN,report,,we,have,sought,to,address,some,of,the,data,that,is, available,and,provide,a,view,of,this,marketplace,based,upon,primary, market,research,we,have,performed,on,researchers,studying,cscs,

3 SchemaEc,RepresentaEon,of,PotenEal,Origins,of, Precursor,Invasive,Cancer,Cells! Source:!!Industry!sources.!

4 Biology,of,CSCs, " The cancer stem cell (CSC) hypothesis states that cells with long life spans must exist within the bulk population of a cancer to sustain the multiple rounds of mutations necessary for cancer formation " According to this model, human cancers originate from tissue stem or progenitor cells, and only a small fraction of these cells (CSCs) have the capacity to proliferate indefinitely " First described in patients with acute myeloid leukemia (AML), CSCs share many of the hallmarks of normal stem cells. For example, both of these cell types have the capacity to self renew and differentiate, however, unlike the highly-regulated self-renewal and differentiation decisions of normal stem cells, it has been suggested that cancer cells undergo uncontrolled self-renewal and abnormal differentiation " Furthermore, CSCs metastasize to distant organs and tissues much like somatic stem cells migrate to distant tissues, and most importantly both cell types exhibit resistance to apoptotic stimuli CSCs Behave like Stem Cells, Exhibit Migratory Behavior, and " Any disturbance of the tightly regulated processes that control self-renewal, cell fate (proliferation vs. apoptosis) and differentiation of tissue stem or progenitor cells may favor the emergence Exhibit of CSCs and Resistance the subsequent to development Apoptosis. of cancer CSCs are Heterogeneous with Respect to Surface " While the precise identity of CSCs in a given type of cancer remains to be identified and is highly controversial at present, it appears that CSCs may arise either from the Marker Properties malignant transformation of a tissue stem or progenitor cell, or alternatively, from the abnormal re-activation of stem cell pathways in a committed progenitor cell " The seemingly distinct (from the bulk tumor) and relatively small population of CSCs possess unlimited self-renewal and proliferation capacity and ultimately potentially sustain tumor growth. However, the proportion of CSCs within the bulk population remains questionable and controversial

5 DescripEon,of,Selected,Markers,for,CSCs,, Marker, Aldehyde! dehydrogenase! Bmi1! CD24! CD44! CD90!(Thy1)! CD105! CD117!(cOkit)! CD133! CD166! EpCAM!(ESA)! Side!Popula?on! DefiniEon, ALDH!gene!superfamily!encodes!detoxifying!enzymes! Normally!measured!by!FACS!aWer!ALDEFLUOR!staining!of!live!cells! Polycomb!protein!that!suppresses!the!INK4A!and!ARF!genes! A!sialoglycoprotein!which!acts!as!a!ligand!for!POselec?n!enabling!cells!to!bind!platelets! Transmembrane!glycoprotein!that!binds!hyaluronan!(HA).! A!glycosylphospha?dylinositolOanchored!protein!(GPIOAP)! A!type!I!integral!membrane!protein! A!receptor!tyrosine!kinase!receptor!for!Stem!Cell!Factor!(SCF)! An!important!marker!for!several!classes!of!CSCs,!probably!not!a!universal!marker!for!CSCs! Ac?vated!leukocyteOcell!adhesion!molecule!(ALCAM)! Epithelial!cell!adhesion!molecule,!a!glycosylated!type!I!integral!membrane!protein.!!Involved! with!components!of!wnt!signaling!in!s?mula?ng!cell!prolifera?on!awer!cleavage!of!epcam! intracellular!domain! Side!popula?on!defines!cells!able!to!efflux!fluorescent!dyes,!appearing!fluorescent!dull!by! FACS.!!This!phenotype!is!usually!dependent!upon!the!ABC!superfamily!of!membrane! transporters!

6 Overview,of,Surface,Phenotypic,Markers,Associated,with,CSCN containing,populaeons,in,various,cancer,subntypes, Cancer Class Glioblastoma, medulloblastoma CD133 + Markers used for identification and/or purification of CSC population Colon carcinoma CD133 +, CD44 +, Lin, EpCAM(ESA) + Mammary carcinoma CD24 /low, CD44 + Lung cancer CD133 + Pancreas carcinoma CD44 +, CD24 +, EpCAM(ESA) +, CD133 + Hepatocellular cancer CD133 + Head and neck squamous cell carcinoma CD44 + Prostate carcinoma CD44 +, α 2 β 1 high, CD133 + Hematological malignancies CD34 +, CD38 " CSCs,with,Different,Surface,Phenotypes,[Surface,Marker,Expression],are,Found,in,Different, Types,of,Cancers., " There,is,SEll,Significant,Disagreement,as,to,whether,there,is,a, Universal,CSC,Phenotype.,

7 Some,Cancer,SubNTypes,and,Associated,CSC, CharacterisEcs, Cancer Sub-type CSC Characteristics Glioblastoma [Aggressive brain tumor] " Glioblastoma stem cells are enriched in a population of cells that express CD133 " Expression of this marker has been linked to poor clinical outcome for the patient " CD133 + cells reside in the perivascular niche in close contact with endothelial cells and this may drive the tumor vasculature Chronic Myeloid Leukemia [CML] " CML stem cells are implicated in disease persistence " Primitive CD34 + CD38 - CML cells have increased expression of the Bcr-Abl protein which is linked with genomic instability and resistance to kinase inhibitors Intestinal Cancer " Cells within the crypts of the stomach, small intestine, and colon that express the GPCR LGR5 are long-lived stem cells " When the tumor suppressor protein APC is lost, these cells give rise to microadenomas and adenomas Breast Cancer " Cells with CSC-like characteristics (ALDH + CD44 high CD24 low ) have been shown to be enriched in patients with breast cancer treated with chemotherapy Prostate Cancer " A subset of cells that are CD133 +, α 2 β 1+, and CD44 + with basal cell characteristics have been shown to be tumorigenic in the prostate CSCs with Different Surface Phenotypes [Surface Marker Expression] and Characteristics are Found in Various Types of Cancers

8 Colorectal,Cancer,Stem,Cells, " Colorectal,cancer,(CRC),is,one,of,the,most,commonly,diagnosed,and,lethal,cancers,worldwide, " CRC, is, a, leading, cause, of, morbidity, and, mortality, worldwide, with, >1.2, million, new, cancer, cases, and, 600,000,deaths,esEmated,in,2008, " CRC, results, from, a, series, of, geneec/epigeneec, alteraeons, and, interaceons, with, micronenvironmental, and,germnline,factors,,that,transform,normal,colonic,mucosa,into,an,aberrant,phenotype, " The, intesene, is, subject, to, a, complex, crosstalk, of, conserved, pathways, such, as, Wnt,, Notch,, and, Hedgehog,,which,control,the,balance,between,proliferaEon,,differenEaEon,,migraEon,,and,renewal, " The, Wnt, pathway,is, responsible, for, endoderm, formaeon, and, exerts, a, fundamental, role, in, crypt, development,,maintenance,and,proliferaeon cnmyc,,cyclin,d1,and,lgrn5,are,its,various,targets, " MutaEons,in,the,APC,gene,(80%,in,sporadic,cancers),,βNcatenin,,or,the,regulatory,proteins,in,the,Wnt, pathway, result, in, consetueve, acevaeon.,, This, may, lead, to, uncontrolled, proliferaeon,, a, shif, from, asymmetrical,to,symmetric,divisions,,and,augmented,cell,survival, " Wnt,signaling,is,also,involved,in,the,process,of,EMT, " Notch,may,drive,tumorigenesis,because,it,potenEates,proliferaEon,,and,inhibits,differenEaEon, " TGFNβ,is,an,inhibitor,of,intesEnal,epithelial,cell,proliferaEon,and,an,inducer,of,apoptosis, " The,Hedgehog,proteins,carry,signals,between,stromal,and,epithelial,cells, " In, colorectal, carcinogenesis,, acevaeon, of, the, phosphoinosiede, 3Nkinase, (PI3K), pathway, results, in, a, rapid,and,excessive,proliferaeon,of,intesenal,stem,cells, " CD133, expression, in, CRC, lines, correlates, with, stem, cell, poteneal,, worse, clinical, prognosis,, and, low, survival, " In, addieon, to, CD133,, other, markers, proposed, as, CSC, markers, include, CD44,, CD24,, CD166,, LgrN5,, and, ALDHN1,

9 Markers,Currently,UElized,to,Characterize,CSCs:, QuanEtaEve,Market,Penetrance, Percent!of!Respondents!Surveyed! 25%! 20%! 15%! 10%! 5%! Respondents!could!choose! 1!marker,!therefore!sum!of!! percentages!=!100%! 0%! " The!Most!Penetrant!Markers!in!the!Research!Community!are!EpCAM!and!CD133! " CD44!is!also!Penetrant!in!the!Research!Community!

10 SegmentaEon,of,the,CSC,Marketplace,visNàNvis, the,intracellular/signaling,pathway,studied! Percent!of!Respondents!Surveyed! 45%! 40%! 35%! 30%! 25%! 20%! 15%! 10%! 5%! 0%! Respondents!could!choose!1!pathway! which!they!study!primarily,!therefore!sum!of!! percentages!=!100%! EMT:,The,Most,Penetrant,Pathway,which,is,Being,Studied,in,CSCs,Space,

11 The,Cancer,Stem,Cells,(CSCs),is,currently,an,amorphous, field,wherein,the,cscs,are,not,well,characterized,and, indeed,there,is,much,controversy,in,the,field,as,to,their, surface,phenotype,,intracellular,pathways,,and,role,in, metastaec,progression, We,have,sought,to,understand,the,marketplace,by, performing,market,surveys,of,researchers,studying, CSCs,,thereby,illuminaEng,the,current,research,trends, Much,remains,to,be,studied,in,this,field,as,the, interrelaeonship,between,cscs,and,ctcs,needs,to,be, clarified, CSCs,may,be,therapeuEc,targets,as,well,as,potenEally, biomarkers,for,cancer,progression,monitoring, In Summary

Lecture 1: Carcinogenesis

Lecture 1: Carcinogenesis Lecture 1: Carcinogenesis Anti-cancer (oncology agents): These are perhaps the most dangerous of drugs, other than the narcotic analgesics. This is due to their toxicities. Killing or inhibiting cancer

More information

Development of Carcinoma Pathways

Development of Carcinoma Pathways The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019

More information

micrornas!as! Biomarkers! Landscape!

micrornas!as! Biomarkers! Landscape! GENReports: Market & Tech Analysis micrornas!as! Biomarkers! Landscape! > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us! Topic Introduction and Scope! The,focus,of,this,GEN,Market,&,Tech,Analysis,Report,is,to,provide,

More information

number Done by Corrected by Doctor Maha Shomaf

number Done by Corrected by Doctor Maha Shomaf number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads

More information

PATHOBIOLOGY OF NEOPLASIA

PATHOBIOLOGY OF NEOPLASIA PATHOBIOLOGY OF NEOPLASIA Department of Pathology Gadjah Mada University School of Medicine dr. Harijadi Blok Biomedis, 6 Maret 2009 [12] 3/17/2009 1 The pathobiology of neoplasia Normal cells Malignant

More information

microrna Therapeutics Heading Towards the Clinic

microrna Therapeutics Heading Towards the Clinic GENReports: Market & Tech Analysis microrna Therapeutics Heading Towards the Clinic > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us Topic Introduction and Scope

More information

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval Biochemistry of Carcinogenesis Lecture # 35 Alexander N. Koval What is Cancer? The term "cancer" refers to a group of diseases in which cells grow and spread unrestrained throughout the body. It is difficult

More information

Lecture 1: Carcinogenesis

Lecture 1: Carcinogenesis Lecture 1: Carcinogenesis Anti-cancer (oncology agents): These are perhaps the most dangerous of drugs, other than the narcotic analgesics. This is due to their toxicities. Killing or inhibiting cancer

More information

TARGETED THERAPY FOR CHILDHOOD CANCERS

TARGETED THERAPY FOR CHILDHOOD CANCERS TARGETED THERAPY FOR CHILDHOOD CANCERS AZIZA SHAD, MD AMEY DISTINGUISHED PROFESSOR OF PEDIATRIC HEMATOLOGY ONCOLOGY, BLOOD AND MARROW TRANSPLANTATION LOMBARDI CANCER CENTER GEORGETOWN UNIVERSITY HOSPITAL

More information

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors

More information

Alan G. Casson FRCSC Professor of Surgery & VP Integrated Health Services University of Saskatchewan & Saskatoon Health Region

Alan G. Casson FRCSC Professor of Surgery & VP Integrated Health Services University of Saskatchewan & Saskatoon Health Region Identification and Characterization of Stem-like Cells in Human Esophageal Adenocarcinoma and Normal Epithelial Cell Lines No disclosures / conflict of interest Alan G. Casson FRCSC Professor of Surgery

More information

TUMOR INITIATING CELLS: THE STEM CELL THEORY OF CANCER

TUMOR INITIATING CELLS: THE STEM CELL THEORY OF CANCER Pr John DE VOS Département d Ingénierie Cellulaire et Tissulaire INSERM 1183 - IRMB Hôpital St Eloi - CHU de Montpellier john.devos@inserm.fr @_jdevos_ TUMOR INITIATING CELLS: THE STEM CELL THEORY OF CANCER

More information

Should novel molecular therapies replace old knowledge of clinical tumor biology?

Should novel molecular therapies replace old knowledge of clinical tumor biology? Should novel molecular therapies replace old knowledge of clinical tumor biology? Danai Daliani, M.D. Director, 1 st Oncology Clinic Euroclinic of Athens Cancer Treatments Localized disease Surgery XRT

More information

609G: Concepts of Cancer Genetics and Treatments (3 credits)

609G: Concepts of Cancer Genetics and Treatments (3 credits) Master of Chemical and Life Sciences Program College of Computer, Mathematical, and Natural Sciences 609G: Concepts of Cancer Genetics and Treatments (3 credits) Text books: Principles of Cancer Genetics,

More information

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology Overview of Cancer Mylene Freires Advanced Nurse Practitioner, Haematology Aim of the Presentation Review basic concepts of cancer Gain some understanding of the socio-economic impact of cancer Order of

More information

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,

More information

Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop

Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop Jan 7 th and 8 th, 2014 Brigitte Gomperts, MD University of California, Los Angeles Lung Structure and Function Airway Epithelial

More information

Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options

Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options Integrated platform technology for discovery of novel molecular targets and

More information

GENReports: Market & Tech Analysis

GENReports: Market & Tech Analysis GENReports: Market & Tech Analysis > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director Select Biosciences, Inc. enal@selectbio.us! The,focus,of,this,GEN,Market,&,Tech,Analysis,Report,is,to,frame,a,

More information

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis. Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)

More information

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

Neoplasia 2018 lecture 11. Dr H Awad FRCPath Neoplasia 2018 lecture 11 Dr H Awad FRCPath Clinical aspects of neoplasia Tumors affect patients by: 1. their location 2. hormonal secretions 3. paraneoplastic syndromes 4. cachexia Tumor location Even

More information

Getting to the root of Cancer

Getting to the root of Cancer Cancer Stem Cells: Getting to the root of Cancer Dominique Bonnet, Ph.D Senior Group Leader, Haematopoietic Stem Cell Laboratory Cancer Research UK, London Research Institute Venice, Sept 2009 Overview

More information

FILE # WHAT PERCENTAGE OF PANCREATIC TUMORS ARE BENIGN

FILE # WHAT PERCENTAGE OF PANCREATIC TUMORS ARE BENIGN 14 February, 2018 FILE # WHAT PERCENTAGE OF PANCREATIC TUMORS ARE BENIGN Document Filetype: PDF 95.97 KB 0 FILE # WHAT PERCENTAGE OF PANCREATIC TUMORS ARE BENIGN What is the percentage of lung tumors being

More information

Section D: The Molecular Biology of Cancer

Section D: The Molecular Biology of Cancer CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Section D: The Molecular Biology of Cancer 1. Cancer results from genetic changes that affect the cell cycle 2. Oncogene proteins and faulty

More information

Oncolytic Virotherapy: Targeting Cancer Stem Cells

Oncolytic Virotherapy: Targeting Cancer Stem Cells Oncolytic Virotherapy: Targeting Cancer Stem Cells Cancer Stem Cells (CSCs) or Cancer Initiating Cells (CICs) A consensus of five defining criteria has been established to affirm the existence of CICs:

More information

Tumorsphere Culture of Cancer Stem Cells (CSC) with the Cancer Stem Cell Medium, Application Note

Tumorsphere Culture of Cancer Stem Cells (CSC) with the Cancer Stem Cell Medium, Application Note Tumorsphere Culture of Cancer Stem Cells (CSC) with the Cancer Stem Cell Medium, Application Note Interest in any of the products, request or order them at Bio-Connect. Bio-Connect B.V. T NL +31 (0)26

More information

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit

More information

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease) CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions

More information

Determination Differentiation. determinated precursor specialized cell

Determination Differentiation. determinated precursor specialized cell Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:

More information

- is a common disease - 1 person in 3 can expect to contract cancer at some stage in their life -1 person in 5 can expect to die from it

- is a common disease - 1 person in 3 can expect to contract cancer at some stage in their life -1 person in 5 can expect to die from it MBB157 Dr D Mangnall The Molecular Basis of Disease CANCER Lecture 1 One of the simpler (and better) definitions of cancer comes from the American Cancer Society, who define cancer as; 'Cancer is a group

More information

Cancer Stem Cells, Therapeutic Implications

Cancer Stem Cells, Therapeutic Implications June 2015 KUWAIT MEDICAL JOURNAL 97 Review Article Ali Ahmad, Zahraa Habeeb, Mohammed Al-Mousa, Ghyath Al-Shawaf, Mariam Al-Awadi, Ardeshir Algooneh Department of Internal Medicine, Al-Amiri Hospital,

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.

More information

Lecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD

Lecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD Lecture 8 Neoplasia II Dr. Nabila Hamdi MD, PhD ILOs Understand the definition of neoplasia. List the classification of neoplasia. Describe the general characters of benign tumors. Understand the nomenclature

More information

Leukemia Research Foundation Scientific Research Grant Recipients

Leukemia Research Foundation Scientific Research Grant Recipients Page 1 of 5 NEW INVESTIGATOR AWARDS Richard Dahl, Ph.D. University of New Mexico $75,000.00 - Ets and Gfi1 family interactions in T cell development T and B cells comprise the adaptive arm of the vertebrate

More information

Cancer stem cells old concepts, new insights

Cancer stem cells old concepts, new insights Review (2008) 15, 947 958 & 2008 Nature Publishing Group All rights reserved 1350-9047/08 $30.00 www.nature.com/cdd Cancer stem cells old concepts, new insights L Vermeulen 1, MR Sprick 1, K Kemper 1,

More information

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX Contents Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX 1 General Aspects of Signal Transduction and Cancer Therapy 1 1.1 General Principles of Signal Transduction

More information

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz Cancer and Oncogenes Bioscience in the 21 st Century Linda Lowe-Krentz December 1, 2010 Just a Few Numbers Becoming Cancer Genetic Defects Drugs Our friends and family 25 More mutations as 20 you get older

More information

Differential Connexin Function Enhances Self-Renewal in Glioblastoma

Differential Connexin Function Enhances Self-Renewal in Glioblastoma CSU ID: 2558414 Name: Sonal Patel Differential Connexin Function Enhances Self-Renewal in Glioblastoma Cancer is one of the most common disease in the US with more than a million people affected every

More information

Stem Cells. Induced Stem Cells

Stem Cells. Induced Stem Cells Induced Stem Cells Stem Cells Mouse and human somatic cells can either be reprogrammed to a pluripotent state or converted to another lineage with a combination of transcription factors suggesting that

More information

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles: Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to

More information

September 20, Submitted electronically to: Cc: To Whom It May Concern:

September 20, Submitted electronically to: Cc: To Whom It May Concern: History Study (NOT-HL-12-147), p. 1 September 20, 2012 Re: Request for Information (RFI): Building a National Resource to Study Myelodysplastic Syndromes (MDS) The MDS Cohort Natural History Study (NOT-HL-12-147).

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

Mohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1

Mohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1 Mohammed El-Khateeb Tumor Genetics MGL-12 July 21 st 2013 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cellular Basis of Cancer Cancer is a collection of diseases characterized by abnormal and uncontrolled growth

More information

Metastasis progression

Metastasis progression Metastasis progression Mieloma multiplo Linear Progression Cancer cells disseminate through the organism after acquiring metastatic features inside the primary cancer Parallel progression Cancer cells

More information

Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:

Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture: Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture: Spandana Baruah December, 2016 Cancer is defined as: «A disease caused

More information

GENReports: Market & Tech Analysis

GENReports: Market & Tech Analysis GENReports: Market & Tech Analysis > Gary Oosta, Ph.D. Biotechnology Analyst, Select Biosciences, Inc. > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us Twitter: @enalrazvi

More information

BIO 302: MARCH 4 & 6, 2014

BIO 302: MARCH 4 & 6, 2014 BIO 302: MARCH 4 & 6, 2014 WEEK 8 LECTURE 2: CANCER AS A COMPLEX ADAPTIVE SYSTEM Dr. George Poste Chief Scientist, Complex Adaptive Systems Initiative and Del E. Webb Chair in Health Innovation Arizona

More information

Cancer Stem Cells & Glioblastoma

Cancer Stem Cells & Glioblastoma Cancer Stem Cells & Glioblastoma JP Hugnot «Brain plasticity, Neural stem cells and Glial tumors» INSERM U1051-UM2 Institut des Neurosciences de Montpellier Montpellier 1-Stem cells and Brain Stem Cells

More information

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Mona A. Abd-Elazeem, Marwa A. Abd- Elazeem Pathology department, Faculty of Medicine, Tanta

More information

CHAPTER 6 SUMMARIZING DISCUSSION

CHAPTER 6 SUMMARIZING DISCUSSION CHAPTER 6 SUMMARIZING DISCUSSION More than 20 years ago the founding member of the Wnt gene family, Wnt-1/Int1, was discovered as a proto-oncogene activated in mammary gland tumors by the mouse mammary

More information

Cancer and sornat ic evolution

Cancer and sornat ic evolution Chapter 1 Cancer and sornat ic evolution 1.1 What is cancer? The development and healthy life of a human being requires the cooperation of more than ten million cells for the good of the organism. This

More information

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia

More information

Overview of mathematical biological models and their application in CML research

Overview of mathematical biological models and their application in CML research Overview of mathematical biological models and their application in CML research March 27 th 2015 Christina Fitzmaurice, MD, MPH Faculty discussants: Vivian Oehler, MD FHCRC/UW William Hazelton, PhD FHCRC

More information

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath Neoplasia 18 lecture 6 Dr Heyam Awad MD, FRCPath ILOS 1. understand the role of TGF beta, contact inhibition and APC in tumorigenesis. 2. implement the above knowledge in understanding histopathology reports.

More information

ANAT3231: lectures overview

ANAT3231: lectures overview ANAT3231: lectures overview Stem Cell Biology Stem Cell Technology Resources: http://php.med.unsw.edu.au/cell biology/ Essential Cell Biology 3 rd edition Alberts Dr Annemiek Beverdam School of Medical

More information

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2 For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?

More information

Carcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples

Carcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Major Principles (cont d) 4. Principle targets of genetic damage: 4 classes

More information

Potentially preventable cancers among Alaska Native people

Potentially preventable cancers among Alaska Native people Potentially preventable cancers among Alaska Native people Sarah Nash Cancer Surveillance Director, Alaska Native Tumor Registry Diana Redwood, Ellen Provost Alaska Native Epidemiology Center Cancer is

More information

Opposing effects of low versus high concentrations of vitamins/dietary ingredients Vitamin C and niacin on colon cancer stem cells (CSCs)

Opposing effects of low versus high concentrations of vitamins/dietary ingredients Vitamin C and niacin on colon cancer stem cells (CSCs) Opposing effects of low versus high concentrations of vitamins/dietary ingredients Vitamin C and niacin on colon cancer stem cells (CSCs) Colorectal cancer is one of the global causes of cancer deaths.

More information

REVIEWS. Stem cell fate in cancer growth, progression and therapy resistance

REVIEWS. Stem cell fate in cancer growth, progression and therapy resistance REVIEWS Stem cell fate in cancer growth, progression and therapy resistance Nikki K. Lytle 1,2,3, Alison G. Barber 1,2,3 and Tannishtha Reya 1,2,3 * Abstract Although we have come a long way in our understanding

More information

Introduction to Cancer Biology

Introduction to Cancer Biology Introduction to Cancer Biology Robin Hesketh Multiple choice questions (choose the one correct answer from the five choices) Which ONE of the following is a tumour suppressor? a. AKT b. APC c. BCL2 d.

More information

Stem cells in homeostasis and cancer of the gut

Stem cells in homeostasis and cancer of the gut Heijden and Vermeulen Molecular Cancer (2019) 18:66 https://doi.org/10.1186/s12943-019-0962-x REVIEW Stem cells in homeostasis and cancer of the gut Maartje van der Heijden and Louis Vermeulen * Open Access

More information

Cancer Fundamentals. Julie Randolph-Habecker, Ph.D. Director, Experimental Histopathology Shared Resource

Cancer Fundamentals. Julie Randolph-Habecker, Ph.D. Director, Experimental Histopathology Shared Resource Cancer Fundamentals Julie Randolph-Habecker, Ph.D. Director, Experimental Histopathology Shared Resource Cancer Overview Leading cause of death in US 1.2 million diagnosed each year More common after age

More information

Cancer stem cells: the lessons from precancerous stem cells

Cancer stem cells: the lessons from precancerous stem cells Received: 10 th August 2007 Accepted: 12 th November 2007 Cancer stem cells: the lessons from precancerous stem cells Jian-Xin Gao Department of Pathology and Comprehensive Cancer Center, Medical Center,

More information

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl Chapt. 18 Cancer Molecular Biology of Cancer Student Learning Outcomes: Describe cancer diseases in which cells no longer respond Describe how cancers come from genomic mutations (inherited or somatic)

More information

CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT

CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT Glioblastoma WHO Grade IV Glioma Heterogenic Undiffenrentiated phenotype 50% of all Gliomas Around 600 patients

More information

Stacey J. Butler. A Thesis presented to The University of Guelph

Stacey J. Butler. A Thesis presented to The University of Guelph Characterization of human colorectal cancer stem cells and their role in chemoresistance by Stacey J. Butler A Thesis presented to The University of Guelph In partial fulfillment of requirements for the

More information

CELL CYCLE REGULATION AND CANCER. Cellular Reproduction II

CELL CYCLE REGULATION AND CANCER. Cellular Reproduction II CELL CYCLE REGULATION AND CANCER Cellular Reproduction II THE CELL CYCLE Interphase G1- gap phase 1- cell grows and develops S- DNA synthesis phase- cell replicates each chromosome G2- gap phase 2- cell

More information

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz October 11, 2013

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz October 11, 2013 Cancer and Oncogenes Bioscience in the 21 st Century Linda Lowe-Krentz October 11, 2013 Just a Few Numbers Becoming Cancer Genetic Defects Drugs Our friends and family 200 180 160 140 120 100 80 60 40

More information

The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge The mutations that drive cancer Paul Edwards Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge Previously on Cancer... hereditary predisposition Normal Cell Slightly

More information

From crypt stem cell to colorectal cancer

From crypt stem cell to colorectal cancer 19 3 2007 6 Chinese Bulletin of Life Sciences Vol. 19, No. 3 Jun., 2007 1004-0374(2007)03-0321-05 ( 510405) Wnt Notch BMP R735.35; R730.21 A From crypt stem cell to colorectal cancer WEN Bin*, CHEN Weiwen

More information

About OMICS Group Conferences

About OMICS Group Conferences About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of

More information

NGS Gateway Lab Services

NGS Gateway Lab Services TM NGS Gateway Lab Services Accelerating Precision Medicine Design a Complete Genomic Testing Portfolio with Turnkey Assays About NGS Gateway Lab Services TM Designed to provide a gateway to your own in-house

More information

oncogenes-and- tumour-suppressor-genes)

oncogenes-and- tumour-suppressor-genes) Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging

More information

CANCER = Malignant Tumor = Malignant Neoplasm

CANCER = Malignant Tumor = Malignant Neoplasm CANCER = Malignant Tumor = Malignant Neoplasm A tissue growth: Not necessary for body s development or repair Invading healthy tissues Spreading to other sites of the body (metastasizing) Lethal because

More information

Roles of microrna-mediated Drug Resistance in Tumor Stem Cells of Small Cell Lung Carcinoma

Roles of microrna-mediated Drug Resistance in Tumor Stem Cells of Small Cell Lung Carcinoma AD Award Number: W81XWH-12-1-0479 TITLE: Roles of microrna-mediated Drug Resistance in Tumor Stem Cells of Small Cell Lung Carcinoma PRINCIPAL INVESTIGATOR: Kounosuke Watabe, Ph.D. CONTRACTING ORGANIZATION:

More information

Triple Negative Breast Cancer

Triple Negative Breast Cancer Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional

More information

Aberrant cell Growth. Younas Masih New Life College of Nursing Karachi. 3/4/2016 Younas Masih ( NLCON)

Aberrant cell Growth. Younas Masih New Life College of Nursing Karachi. 3/4/2016 Younas Masih ( NLCON) Aberrant cell Growth Younas Masih New Life College of Nursing Karachi 1 Objectives By the end of this session the learners will be able to, Define the characteristics of the normal cell Describe the characteristics

More information

Summary and Concluding Remarks

Summary and Concluding Remarks Summary and Concluding Remarks Chapter 6 The intestinal epithelium provides an excellent model system for investigating molecular mechanisms regulating cell lineage establishment, stem cell proliferation,

More information

Mohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學

Mohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學 Mohammed El-Khateeb Tumor Genetics MGL-12 May 13 th 2014 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cancer Genetics Types of Genetic Alterations in Cancer Evidence that Mutations Cause Cancer Multistage Model

More information

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber jweber@dom.wustl.edu Oncogenes & Cancer DNA Tumor Viruses Simian Virus 40 p300 prb p53 Large T Antigen Human Adenovirus p300 E1A

More information

OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors

OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors Jakob Dupont MD MA CMO, SVP: OncoMed Pharmaceuticals Adjunct Clinical Faculty: Stanford University

More information

Is aspirin ready for colorectal cancer chemoprevention and adjuvant therapy?

Is aspirin ready for colorectal cancer chemoprevention and adjuvant therapy? Is aspirin ready for colorectal cancer chemoprevention and adjuvant therapy? Robert Benamouzig Service de Gastroentérologie Hôpital Avicenne Bobigny, France Aspirin and Colorectal carcinogenesis Aspirin

More information

Therapeutic implications of cancer stem cells. Cédric Blanpain, MD, PhD Laboratory of stem cells and cancer WELBIO, Université Libre de Bruxelles

Therapeutic implications of cancer stem cells. Cédric Blanpain, MD, PhD Laboratory of stem cells and cancer WELBIO, Université Libre de Bruxelles Therapeutic implications of cancer stem cells Cédric Blanpain, MD, PhD Laboratory of stem cells and cancer WELBIO, Université Libre de Bruxelles Stem cell properties Differentiation Self-renewal Tumor

More information

Hypothesis of Cancer Stem Cells and Stem Cells of Head and Neck Cancer Biomarkers for their Identification

Hypothesis of Cancer Stem Cells and Stem Cells of Head and Neck Cancer Biomarkers for their Identification C CRIMSON PUBLISHERS Wings to the Research Modern Research in Dentistry ISSN 2637-7764 Review Article Hypothesis of Cancer Stem Cells and Stem Cells of Head and Neck Cancer Biomarkers for their Identification

More information

Stem cells are undifferentiated cells which are maintained within a specific niche. A stem cell

Stem cells are undifferentiated cells which are maintained within a specific niche. A stem cell Abstract Stem cells are undifferentiated cells which are maintained within a specific niche. A stem cell niche is a microenvironment of cells that maintain stem cell functionality, and one example is the

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

Multistep Carcinogenesis

Multistep Carcinogenesis Multistep Carcinogenesis M.Rosemann, Institute for Radiation Biology Helmholtz Center Munich, Research Centre for Health and Environment The Hallmarks of Cancer D.Hanahan, Cell 2011 The Hallmarks of Cancer

More information

Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge Tumour Structure and Nomenclature Paul Edwards Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge Malignant Metastasis Core idea of cancer Normal Cell Slightly

More information

Overview of the core ideas in cancer research

Overview of the core ideas in cancer research Overview of the core ideas in cancer research Paul Edwards Cancer Research UK Cambridge Institute and Department of Pathology, University of Cambridge This lecture Overview of the ideas that provide the

More information

icamp: Cancer biology tutorial II: recent developments in tumor biology, experimental methodology, and reference identification

icamp: Cancer biology tutorial II: recent developments in tumor biology, experimental methodology, and reference identification icamp: Cancer biology tutorial II: recent developments in tumor biology, experimental methodology, and reference identification Stem cells and the environment in the adenoma-carcinoma sequence (Medema,

More information

Developing Better Medicine

Developing Better Medicine SURF 2013 Marietta L. Harrison, PhD Director, Oncological Sciences Center in Discovery Park Professor, Medicinal Chemistry and Molecular Pharmacology How we do it today One size fits all Medicines aren

More information

ANAT3231: lectures overview

ANAT3231: lectures overview ANAT3231: lectures overview Stem Cell Biology Stem Cell Technology Resources: http://php.med.unsw.edu.au/cell biology/ Essential Cell Biology 3 rd edition Alberts Dr Annemiek Beverdam School of Medical

More information

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives 2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,

More information

Lesson 19 Study Guide: Medical Biotechnology Cancer Treatment

Lesson 19 Study Guide: Medical Biotechnology Cancer Treatment URI CMB 190 Issues in Biotechnology Lesson 19 Study Guide: Medical Biotechnology Cancer Treatment 11. There have been genes that have been identified to be associated with certain types of cancer. Microarrays

More information

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Molecular Markers Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Testing methods Rationale for molecular testing

More information

mirna Dr. S Hosseini-Asl

mirna Dr. S Hosseini-Asl mirna Dr. S Hosseini-Asl 1 2 MicroRNAs (mirnas) are small noncoding RNAs which enhance the cleavage or translational repression of specific mrna with recognition site(s) in the 3 - untranslated region

More information

Phoenix Molecular Designs

Phoenix Molecular Designs Phoenix Molecular Designs DESIGNING PRECISE THERAPEUTICS TO REVOLUTIONIZE TREATMENT Our Team Dr. Sandra Dunn, Ph.D. Dr. Anna Stratford, Ph.D. Dr. Aarthi Jayanthan, Ph.D. Dr. Zaihui Zhang CEO, CSO UBC Professor

More information